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Objeclives. The aim of this study was to delerndne the efficary 
of implantable ~ardiover,er~eBbrilIntl; (ICD) therapy in survi- 
vors if sudden cardiac de&b In whom no venlricutar arrhythmias 
can be induced with progrmmrd rlsrlrkal stimulation. 
Background. Survivors ol sudden cardiac death in whom 
ventricular arrhythmias cunnu( he induced witk programmed 
electrical stimulation remain at risk for recurrence of serious 
arrhythmia?. Optbai protection to prevent sudden death in thee 
ptirne is uncerDin. This sludy cornpares survival In the rub&al 
survivors ol sudden cardiac deafh with that ol paGene ,rea,rd 
with or without 811 ICD. 
Methods. h retroqxctive study was pwformed on 194 consee. 
utivc survivors 01 primary sudden death who had 56 beats of 
venlricular tachycardia induced with programmed electrical stim. 
elation with at Ienst three extrastimuli. Ninety&e ptkntr 
received a” ICD and 95 did no,. 
Resdts. There were no significant differences between the two 
groups in presenting rhylhm, number of prior myocardint Marc- 
lions or use ol antiarrhythmic agenls. Pslirnts treated with an 
ICD were :ioun&r (55 + 16 YS. 59 f II years, p = 0.03) and bad 
a kwr incidence cd coronq srtrry dheve (48% vs. 63%; p = 
0.04) and a tower eJec,kw~ fraction 10.43 d 0.16 VS. 0.48 t 0.18, 
p = 0.04). There were w signitkm, dtiTerencw bemeen the 
groups in ule use of revpscularieslion prccedurn or nnttarrbyth- 
mic agent, akr the sudden cnrdiac death. Patlenh treated with 
an ICD hsd P” Improvement in sudda cardiac dealb-free SW. 
viva1 (p = 0.04) b;t the ovtntt survival rate dii not dialer lrom 
that of the wtknts not so treated C = 0.91). A mMwtate 
Concluhw. Survivors al sudden cardiac d&b in whom 110 
arrhythmia cold bc induced with programmed electrical stint. 
~Lalk~ raudncd at r&k ror srrhylkmis mumnce. Althwgh tke 
proportia oi daths sttribMed to arrhythmias I*SJ kws In tke 
patknb treated with a” ICD, tbts tbrapy dM no( s$nltkantty 
impraw overall survival. 
(I Am Cdl CardJo 1993:2J:JJ86-92) 
Patients who are resuscitated from an episode of sudden 
cardiac death remain at risk fur arrhythmia rccurrcnce (1.2). 
Electrophysioloqic studies huve been used as a method to 
identify high risk patients. In patients with inducible arrhyth- 
mia, such studies can be usid to guide drug therapy t3) and 
to identifv ntients who might benctit from surcical 14) or 
device CSi iherapy. Patients-without inducible &hythmiaa 
remain at risk for recurrent adden cardiac death with Z-year 
recurcnce rates of 4% to 15% (6-11). In these patients. the 
findings ~felectrophyaiologic studies cannot be used toguide 
therapy. Many physicians now use implantable cardiaverter. 
dehorillators Wlls) in this brow in an attempt to prevent 
sudden death. Recent recommendations from the A&ican 
College of Cardiolorv. American Heari Association and the 
North American S&y of Pacing and Electrophysiology 
support this approach, although it has never been sptxiti- 
tally evaluated in this patient group (15.13 
Because there have been no clear guidelines delineating 
the manag~~~cnt ofsurvivors of sudden death without induc- 
ible arrhytbn.ias. patients have been treated with and with- 
out ICDs in our centers. The purpose of this study was to 
evaluutc he efficacv of ICDs in this subaroup of survivors of 
sudden cardiac death and to determineihosi charwtetistics 
that might identify those patients who might benefit from 
their use. 
Methods 
btienls. In a rctrospectivc study we evaluated 194 con- 
arcutivc survivors uf sudden cardiac death in whom no 
arrhythmias could be induced on clectrophysiologic study. study to be other than ventricular tachycardiaor fibrillation. 
Rrticipatmg Northwest Electrophysiology Society centers Arympromutir ICD discharge: a &vice discharge that OF- 
included Oreron Health Sciences UniverGtv (84 oaticnts), currcd with no antecedent s~motoms. Arrkvrkmic we-nls: 
the Universiyy of Washington (64 patie&). Providence sudden cardiac death or an ap&&iate ICD discharge in tke 
Medical Center. Seattle (28 patientsl. and Stanford Univer- ICDtrcitcd group: sudden cardiic death, aborted sod&n 
shy (16 patients). All patients who underwent elsctrophysi- death. syncope or sustained veatricular tachycardia in the 
ologic studies at our four centers between November 1980 
mic drug effect; 4) iod&ttoo of 56 beats of~ventric~!ar 
and November 1991 were considered except those entered at 
Stanford where inclusion began in September 1984 because 
srrhvthmia on oroammmed electrical stimulation with at 
of a change in inve~.igators. The following entry critetia 
were met by each paint.: I) Jurvival after an out-of-hospital 
sudden cardiac death with sudden collapse and complete 
loss of consciousness requiring caaioversion to res:ore a 
stable rhythm; 2) no evidence of myocardial infarction 
within 14 days of the sudden cardiac death: 3) no signilicaot 
underlying metabolic or electrolyte abnormalities and no 
history of alcohol or drug abuse or evidence ofa proarrhyth- 
patients treated without an ICD. 
FoUow+m. The maioritv of oatients were Mowed UD 
regularly hi rhe kw&&x-s. AdditionI information v&s 
obtained by review of hospitzl and clinic recordr. autopsy 
deaths. In 2 of the 31 deaths. these reviewers seiected 
reports and contact with refeninp, physicians, the patients or 
their families. End points of f&w-up were sodden cardiac 
different death classiiica!ions, and in these cases the final 
death. nonsudden car&c death and noncardiac death. 
Deaths were classified hy two investigators (J.H.M. and 
P.J.K.) who had no knowledge of piont identity ot’ Ike 
presence or absence of att ICD. They were given twrative 
dexription, of a:i available information on the patients’ 
leas; three v&c&r extrastimuli. classification was determ;ned in blinded fashion by B third 
Pragrmnmed rtimnlstion protocol. All antiarrhythmic iwesttfiltor (C.D.M.). 
drugs were discontinued for a period ofat least 5 half-lives or Stattstical atalysb. Standard deviation imemt + SD1 war 
until plasma concentrations were negligible before baseline used as the io:!ex oidispetsionofobserved values. CooCtws 
electrophysiologic study. No patient had previously been varinbles were compxed by using a r statistic and dichotomous 
treated with amiodarone. After each patient gave informed vattables with the chi-square statistic. A p value i 0.05 
consent, multipolar recording and stimhlmion cxkcters were 
positioned in the right atrium. right ventricular apex and His 
bundle. lntmcardia~ and surfvceelectmcardiographic (ECG) 
leads were recorded simultaneously. Tke protocol for all 
m&atts included a minimum of three extrastimuli from at 
ieast one ventricular site (two sites in 86’6) and two basic 
drive cycle lengths (usually @IO and 400 ms) usiw a 2-m, 
rectangular pulse width at twice diastolic threshold. 
Treatment. Inall patients, efforts were made to optintize 
therapy of congestive heart failure and myocardial ischemia 
before electmphysiologic study. All patients underwent cor- 
onary aogiography. Coronary artery bypass grafting or an- 
gioplasty procedures were performed before electmpkysic- 
logic study when clinically indicated (12% of patients). 
Aiter electraphysiologic evaluation, the use of beta- 
rdnrter~ic block& agmtts. the empiric use of class 1 anti- 
orrhythmic agents m amiodarone and treatment with coro- 
nary artery bypass grafting or angirplas~y procedures wre 
determined by each pnticnt’s attending physicians. The use 
of 1CD therapy wets determined by recommendations of the 
attending physician. p&m preference and the availability 
of devices. 
DeAnltions. The following definitions are used. Sudden 
cardiac de&h: unexpected death within I h of the onset of 
symptoms. Nonsudd~n cardiac de& all other deaths 
judged to be from cardiac causes. No~nwdiac denrh: all 
other deaths. Appropriate /CD dischay: a device dis- 
charge preceded hy dizziness. presyncope or syncope or by 
ventricular tact ycardia or ventricular fibrillation docu- 
mented by ECG. lnappropria~r ICD .!whurpr: . device 
discharge that occurred during rhythms proved by ECG 
Iwo-t&d) was consider& s$ni6cant. 
Actuxial curves fooi mortality and survival free of sudden 
cardia; desk were conswucted by using the Kaplan-Meier 
method (14) and comaared with the Breslow-Cehao statistic 
(I’). Length of fol!&up was considered to be the time 
bet -en eke index eveni to the date of death or date the 
pmieut was last known to be alive. An istentton-l*:rcat 
&dysis was used and patients remained in their initia: 
therapemic group even ii they crossed over to the altcmatc 
therapy. Survival is shown as the pmbobility of survival * 
SEE. 
The effclrt of relevant cwxiates on recurrent arrhythmic 
events was evaluated usior. a Car proportional hazar& 
model. The elfezt of nine variables on the lime to a rectwat 
arrhythmic event was tested: age (CM vs. =@I yews), 
gender. presence of remote myocardial mfttrction. presence 
of coronary artery diwse, presenting arrhythmia (ventricu- 
lar fibrillation or tttchywdia or asystole) at the time of 
sudden cardiac death, left ventricular ejection frrctian 
(<O..ltl YS. 50.40). pressoce of a left “entricolar aneurysm. 
use of beta-blockers after sudden cardiac death attd use of 
revascularization procedures (coronary artery surgery or 
angioplasty. or both). After testing the univariate signifi- 
cmxe of individual variables in the Cox model, relations 
demonstrating important prediction of events (p < 0.20) 
were investigated further within the fmmework of stepwise 
mtdtiple re!&~ion using the Cox proportional hazards 
model to examine their joint eiiects on outcome. Variables 
resulting in the best possible fit were included in the final 
model. The relative risk and 95% confidence interval asro- 
&ted with each variable in the final model. reflecting the 
Tnhlr 1. Characteristics of the Study Gmup 
Pu!ie”t Group 
relative contribution of the variable to the hazard of earlier 
arrhythmic events, were calculated after adjustment for the 
influence of the remaining variables in the model. 
Results 
Patient charac~eristies. Of the 194 patients who were 
evaluated, YY received an ICD and 95 did not (Table I). 
Patients receiving an ICD were significantly younger (p = 
0.03:, were less likely to have coronary artery disease (p = 
0.04). 2nd had B lower ejection fraction (p = O.U4) than did 
those who did not receive the device. There war no uthcr 
significant diLrexes between the groups (Table I). There 
were no significant di5erences between the twogmups in the 
use of class I antiarrhythmic agents, amiodaroce or revas- 
cularization procedures aftc.r sudden death (Table 2). Fol. 
low-up was completed in 99% of patients in the lCD.treated 
group over a median of 22 months and in 97% of patients 
treated without an ICD over a median of 36 monrbs. 
F!gwe 1. Overall survival comparing the groups treated with and 
withoul an implantable cardioverter,dchbdllator IICD) (p = 0.9%. 
N = number cf palhnts. 
Survival. The wwall survival rate was 0.88 L 0.M at 24 
months for the ED-treated patients and 0.90 ? 0.03 for the 
patients without an ICD (Fig. I) with no significant diier- 
ences in actuarial survival between the groups :p = O.!X). 
Tl:e 24-month sudden cardiac death-free survival rate was 
0.97 i: 0.02 for the ICD-treated patients and 0.90 t 0.03 for 
the patiettts without an ICD (Fig. 2). Over the entire fol- 
low-up p&d the ICD-treated palients were less likely to die 
of sudden cardiac death than were thnsc without an ICD 
(p = 0.05;. Over a median follow-up interval of 22 months, 
there were 12 deaths in the ICDtreated patients: 3 open- 
rive, 3 sudden cardiac. 4 nonsudden cardiac and 2 noncar. 
disc. Over a median follv#-up interval of 36 months there 
were 19 deaths in the patients withoat aa ICD: 14 sudden 
cardiac, 4 flnnsuddrn cardiac and I noncardiac. 
Five of the patienls in the ICPIreated group who died 
were. being treated with antiarrhylhmic agents (two with 
procainamidc, two with quinidinc and one with amicdarone). 
F&w 2. Sudden cardiac death-free survival comparing the @vups 
treated with and without an inplantable eardiovcnardc6hrillalor 
(p = O.LIS). Abbreviations as in Figure 1. 
Four of the deaths were nonsudden cardiac deaths and the 
pntirnt being treated with quinidine died suddenly. Eight of 
the p&nts who did no: receive an ICD died while receiving 
antiarrhylhmic therapy @Gline in three. procaioamide in 
two, mexiletine in one aad amiodarone in two): five of these 
eight patients died suddenly. The number of patients was too 
smalI to perform a meaningful statistical analysis to deter- 
mine whether proarrhythmia may have caused some of these 
deaths. 
Because of the observed baseline ditierences in age. 
ejection fraction and the prevalence of coronwy artery 
disease. a Cox proportional hazards model of survival was 
used to adjust for these factors. There was no significant 
diierence in survival between the groups with and without 
an ICCD after this adjustment fp = 0.91). However, the 
ICLkeated patiests had a sianiticaotly better sudden car- 
diac death-t&e survival f&e ip = O.Wi after adjustment. 
Arvbylhmle event r&s. The ICDtreated patients bad a 
s$eitirentty higher arrbylhmic event rate then that of the 
patients without an 1CDl.p = 0.004. Fig. 3). AtZ4monthr the 
proportion event-free was 0.70 + 0.0s for the ICD-treated 
group aad 0.88 k 0.04 for the group without an ICD. 
The patients treated without an ICD had 20 arrhythmic 
events. of which 16 were fatal. The two nonfatal events 
consisted of syncopal ventricular rachycardia at 3 years in 
one patient and ventricular fibrillation at 6 months in the 
orhe;. The first patient was treated with amiodarone and died 
18 months later of congestive heart ftiailure. The second 
patient received an ICD. 
Of the 99 patients who received an ICD. 28 had arrhyth- 
mic events in follow-up: 3 events resulted in sudden death 
and 28 were accompanied by appropriate ICD discharges. 
All three patients who died suddenly had previously experi- 
enced appropriate ICD discharges. In addition, 6% of pa- 
tients had documented inappropriate ICD discharges and 
23% had asymptomatic ICD discharges. 
Predictors ef arrhythmlc even&. To detemdsre preimplan- 
tation characteristics that predict recurrent arrhythmic 
events. univariate and na.ltivaiate analyses were performed 
(Table 31. In the univariatr analysis. the presence of coro- 
nary artery disease, an ejection fraction co.40 and the 
history of a prior myocardial infarction were sign&ant 
predictors of recurrent arrbythmic events. In the multiwi- 
ate analysis, only comnwy anery disease aad an ejection 
fraction~<OMJ w&e predi&e. 
Subgroup amdysis. Because I& ventricuk ejectioa fmc+ 
tion has been consistently demonstrated lo correlate with 
outcome in survivors of sudden death (3.6.7). actuarial 
analysis was perforated, sttatlled by eject& fr&ms (Ta- 
ble 4). In this analysis aa ejection fractiw cuto6 value of 
0.30 was used. When the ejection fraction was <0.30, the 
sudden cardiac de&-free survival and overall survival rates 
were not significantly diierent between the patients treated 
with or without an ICD. In the patients with an ejection 
frection n0.30, the K&treated pa&Is had a higher sudden 
cardiac death-free survival rate (P = 0.02). Overall survival 
was not statistically significantly improved (p = 0.44) for the 
patients with an ICD.. 
Fmwotte wdiettts had no evidence of structural heart 
disease; 22 ofihese received an ICD and 19 did not. There 
were no deatbs in either group. Five of the pltients with an 
ICD had an appropriate device dircharpe. 
Eu&al mm@ations. There were two initial operation- 
related deaths in tk ICD-treated patients. Both patients had 
concomitant eoroaaty bypass stwgery. never regained con- 
sciousness after the operation and died of multisystem 
failure after a prolonged postoperative course (64 and Sl 
days, respectively). A third patient died of sepsis caused by 
a wound infection 17 days after battery repkcment 26 
months after the initial implantation. 
Cmssovers. Three patients in the ICDgroup crossed over 
to non-ICD treatment. In one patient, the ICD vns removed 
because of a Sfophylococcus aur~~s infection after 58 days 
and in another because of clinical evidence of constrictive 
pericarditia thought to be caused by the epicardial patches 
after 224 days. Both patients are still sur&ing. In the third 
patient adequate defibrillation thresholds could not be 
achieved and the ICD pulse generator was never placed. He 
was treated with amiodarone and is alive after 8 months of 
follow-up. 
One patient was initially intended to be treated without an 
ICD but 6 months later. after a second eviscde ofventricular 
fibrillation, an ICD wa; placed. He is itill surviving after I 
month of follow-up. 
Discussion 
The outcome in survivors of an out-of-hospital sudden 
cardiac death in whom ventricular tachyarrhythmias could 
not be induced with programmed electrical stimulation and 
who received an ICD was compared with that in a similar 
group of patients who were treated without an ICD. Both 
arows remained at risk for sudden cardiac death. Treatment _ 
with an ICD decreased the incidence of sudden death but did 
not change overall survival. 
Survival. The 9% incidence rate of sudden cardiac death 
at 2 years in the patients without an ICD is consistent with 
reported rates of 4% to IS% in other recent trials (6-11). 
Only 7% of the ICD-treated patients in the present study had 
diod suddenly at 2 years. This improvement in sudden 
cardiac death-free survival. presumably due to the ICD, is 
similar to that found in broader groups of patients with 
vc&cular arrhythmias (5.15-21). However, the results of 
ICD therapy should be measured by its effect on survival. 
Kim et al. (22) and Guarnieri et al. (23) have demonstrated 
that sudden death rates alsne overestimate the efficacy of 
these devices. They suggest that although ICD therapy may 
prevent sudden death, the operative mortality rate and 
nonsudden cardiac death rate may olfset the gains made. In 
the present study, the surgical mdnality rate was 3%, which 
is within the range of that of other published series (1.17). It 
85% compared with a projected survival rate of 31% at 3 
years. Unfoflunately, this method may also be unreliable. 
Currently approved ICDs do not have ECG monitoring 
capabilities and it is therefore difficult 10 determine which 
may seem that this 3% rate would not have a significant discharges were truly appropriate. Additio’ Ily, many 
impact on agroup of this size. Ewever, because event ra!es 
are low in this patient group, it consti!uted 25% of the deaths 
in the ICD-treated patients. These deaths in combination 
with those due IO progressive congestive heart failure and 
other nonsudden cardiac deaths negated the improvement in 
sudden death survival. 
Comph with other studii. To our knowledge no 
previously published studies have *valuated the efficacy of 
ICDs in survivors of sudden cardiac death without inducible 
arrhythmias. However, there are several published studies 
(5.1~21) regarding the et&cy of these devices in broader 
groups of patients with ventricular arrhythmias. Three meth- 
ods have been used to estimate the impact of ICDs on patient 
survival. 
The grsr method is simpiv to report padent survival 
statistics without cam&son with a coawrent control 
grmtp. Winkle et al. (5) reported on their experience in 270 
patients (5). The I- and 3.year sudden death rates were 1% 
and 4% and total death rates were 8% and la%%, respectively. 
This study and others like it have been compared with 
historical series of medical and surgical therapy and these 
comparisons ssggest a marked improvement in survival with 
1CD therapy (24). As with many new therapics, however, 
this method of comparison can be misleading beeawe the 
patients studied may have been significantly different. 
Therefore caution must be used when using such data to 
make judgments about the overall impact on mortality. 
The second method that has been used utilizes each 
patient as his own control. “Appropriate ICD discha&’ 
are then used as an end point with the assumption that the 
patient would have died without the ICD in place. These 
studies have also suggested a dmmatic improvement in 
survival with ICD therapy. Fogoras et al. (20) reparted on 
their experience with I19 patients with were underlying 
heart disease using this method. The actual survival rate was 
rhythms treated appropriately by the ICD may not have 
resulted in death. These limitations may ledd to ovcre$tima- 
tion of ICD benefit. 
The third method has compared a group of ICD recipients 
with a control group. Newman et al. (21) rctrospcctivcly 
compared 60 patients who presented with malignant ventric- 
ular arrhythmias and received an ICD with I20 patxnts 
matched for age. leir ventricular ejection fraction, type of 
heart disease, type of presenting arrhythmia duration, and 
amiodarone re$~nse.~The tC&e&d >aticnts had an 
improved tlrobabilitv of survival 11) < 0.0:: with a ISmonth 
x&al r&c of O.sS compared ‘with 0.72 in the control 
patients. The results cannot be directly compared with those 
of the present study because a ditierest patient group was 
evaluated (most had ventricular arrhythmias induced with 
programmed stimulation). 
SubgmupaaaIysir. In the subgroup analysis WC observed 
‘10 improvement in survival due to an ICD in the patients 
with a low ejection frac!ion. Because patients with a !ow 
ejection fraction are at the greatest risk of sudden death 
recurrence (3.7), they would seem to be the nwst likely to 
benefit from an ICD. They didn’t, probably in part because 
they had had the highest surgica! mortality raw and inci- 
dence of nansudden cardiac deaths. The sudden cardiac 
death-free surviva! was also not rigniftcantly improved in 
these patients with a low ejection fraction. 
Amonp. the MIettts with an eiection fiuctian ~0.30. the 
ICO-t&&J pa&nts had a high& survival rate at 2 years 
(0.96 vs. 0.90, p = NS). These patients have a lower risk of 
sudden death than do patients with worse left ventricular 
function but they also have a lower operative risk and lower 
risk of other cardiac mortality. 
In the patients with no other evidence of heart disease 
there were no deaths in either therapy group. This outcome 
is consistent with another multicenter report suggesting that 
this is a low risk group (26). The presence of five patients in 
the ICPtrcated group with “appropriate ICD discharges” 
again m&s the question that the time to first shock method 
may overestimate the efficacy of these devices. An altema- 
tive exp!anation would be that the ICBtreated patients were 
selected appropriately. that they were higher risk patients 
aad that they banelited from the shocks. 
LImItatIom d tka study. It is possible that selection 
biases may account for the lack of improvement in survival 
in the ICD-treated patients. Patients more likely to be at risk 
of recurrent sudden cardiac death may have received an 
ICD. Indeed one would expect that we would have at- 
tempted to place an ICD in those most likely to need one. 
However, the factors that drove these decisions were in 
most cases mH)t based on such cliicai variables. Forty-five 
parcent of the patients who did not receive an ICD were 
treated before the device was available and I I% had had sn 
ICD recommended but declined such therapy. Additionally 
other Factors, including advanced age, hi surgical risk and 
complex other medical problems. may have influenced 
avoidance of ICD use in sicker patients. There were slip 
diBerences in age, ejection fraction and the presence of 
cownary artcy disease between the !w groups; however, 
in regression modelinE of survival. these factors did not 
affect the overall or sudden cardiac death-free survival 
comparison between patients in the ICD and non-ICD 
gr0CPS. 
11 is possible that other therapies such as treatment with 
angioiensin-convetlittg ettzytne inhibitors may have altered 
the results in these patients because these agents have been 
shown to improve survival in patients with heart failure (26). 
However. because mcrc of the patien.s in the LCD group 
were treated during the period when augiatensin-convening 
enzyme inhibitors were routinely used. this group would 
have been more likely to benefit and it is therefore unlikely 
that such treatment would have masked a benefit of the ICD. 
Decpite attempts to determine differences between !be 
two groups, we cannot exclude the possibility that a distin- 
guishing varilible was not analyzed. Daly a prospective 
randomized triai would eliminate the possibility of thia typ 
of selection bias. However. such a trial in this group will 
require large numbers of patients and a long p&al of time to 
.~mplet”. given tbc low event rate and the relatively low 
..umbers of nuninducible sudden death suwivurs seen in any 
one center. 
Clinical implicatioxw Sudden cardiac death remains a 
major health problem. with an estimated 3OO.MHl episodes/ 
year in the tiuitcd States (271. Implantable cardiovertcr- 
defibrillator therapy is a promising approach and surely has 
a role in treating many of these patients. As techniques 
became refined and newer generations of impmved devices 
become available, the role if ICD therapy <ill continue to 
increase. If this therwv hzd low cost and littie associated 
morbidity and tnortaI&, it would bc difficult to withhold 
from any patient at increased risk of sudden death. How- 
ever. it remains att expensive step that is associated with 
significant morbidity and monality. The present data suggest 
that ICD therapy prevents rccurrcncc of sudden cardiac 
death but does wt improve overall survival in the subgroup 
of survivors of the a&rt in whom no arrhythmias can be 
induced with electmphysiolaaic study. We therefore recom- 
mend caution in ap$y& this therapy to aI1 such survivors 
until further ittfortaation is available. Cxeful prospective 
trials will be needed to define the subgroups among these 
patients who will most benefit from the use of au ICD. 
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